Aim and Scope
Aim and Scope of Biotechnology and Regenerative Sciences
Aim:
Biotechnology and Regenerative Sciences is a cutting-edge interdisciplinary journal dedicated to advancing the understanding and application of biological technologies and regenerative approaches that transform healthcare, agriculture, and industry. The journal aims to bridge fundamental research with translational innovations, fostering discovery and the development of sustainable, personalized solutions for human and environmental well-being.
Scope:
The journal covers a broad spectrum of innovative topics, including but not limited to:
-
Molecular and Cellular Biotechnology: Advances in molecular engineering of nucleic acids, proteins, enzymes, and synthetic biology for therapeutic and industrial applications.
-
Regenerative Medicine and Tissue Engineering: Innovative stem cell therapies, biofabrication, organoids, gene editing (e.g., CRISPR), and biomaterials designed to restore or replace damaged tissues and organs.
-
Systems and Synthetic Biology: Design and modeling of complex biological systems to create efficient biological circuits and biosynthetic pathways for novel biomolecules.
-
Agricultural and Environmental Biotechnology: Genetic improvement of crops for stress resistance and enhanced nutrition, bioremediation technologies, and sustainable bioenergy production.
-
Biomedical Innovations: Translational research on diagnostics, drug delivery systems, personalized medicine, immunotherapy, and biomarker discovery.
-
Ethical, Regulatory, and Commercial Aspects: Navigating the societal, ethical, and commercial challenges of advancing biotechnology and regenerative science into practical healthcare and industry solutions.
-
Interdisciplinary Collaborations: Integrating insights from biology, engineering, material sciences, computational biology, and clinical sciences to accelerate innovation.
This journal seeks to promote cutting-edge research that pushes the boundaries of biotechnology and regenerative sciences, fostering technology transfer into clinical and commercial development while emphasizing ethical responsibility and sustainability.
